Back
Sarepta Therapeutics Vs. Winmark Industry Stock Comparison
Sell
31
SRPT
Sarepta Therapeutics
Last Price:
$13.61
Seasonality Move:
29.39%
Buy
57
WINA
Winmark
Last Price:
$377.75
Seasonality Move:
4%
Sell
31
Sarepta Therapeutics (SRPT)
is a Sell
Is Sarepta Therapeutics a Buy, Sell or Hold?
-
The current Sarepta Therapeutics [SRPT] share price is $13.32. The Score for SRPT is 31, which is 38% below its historic median score of 50, and infers higher risk than normal.
-
SRPT is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
SRPT Stock Price Chart
What is Sarepta Therapeutics's stock price today?
-
The Sarepta Therapeutics share price today is $13.32The current trend is moderately bullish and SRPT is experiencing slight buying pressure.
WINA Stock Price Chart
SRPT Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 4.56 | Buy |
Relative Strength Index (14 RSI): | 29.8 | Sell |
Chaikin Money Flow: | 1711595 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (15.17 - 23.11) | Sell |
Bollinger Bands (100): | (23.35 - 78.03) | Sell |
WINA Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 103.53 | Buy |
Relative Strength Index (14 RSI): | 42.8 | Sell |
Chaikin Money Flow: | -16254 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (361.41 - 416.67) | Sell |
Bollinger Bands (100): | (327.27 - 410.97) | Buy |
SRPT Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 17.8 | Sell |
20-day SMA: | 17.95 | Sell |
50-day SMA: | 28.6 | Sell |
200-day SMA: | 85.51 | Sell |
8-day EMA: | 15.61 | Sell |
20-day EMA: | 11.18 | Buy |
50-day EMA: | 5.91 | Buy |
200-day EMA: | 1.72 | Buy |
WINA Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 374.35 | Buy |
20-day SMA: | 375.82 | Sell |
50-day SMA: | 404.28 | Sell |
200-day SMA: | 379.2 | Sell |
8-day EMA: | 344.75 | Buy |
20-day EMA: | 236.31 | Buy |
50-day EMA: | 122.95 | Buy |
200-day EMA: | 35.45 | Buy |
Sarepta Therapeutics Earnings Growth & SRPT Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.24 per share, an increase next quarter of $0.82 per share, a decrease this year of $6.46 per share, and an increase next year of $5.61 per share.
Winmark Earnings Growth & WINA Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Sarepta Therapeutics Technical Analysis
Jul 8 | Jul 9 | Jul 10 | Jul 11 | Jul 14 | Jul 15 | Jul 16 | Jul 17 | Jul 18 | Jul 21 | |
---|---|---|---|---|---|---|---|---|---|---|
Jul | ||||||||||
08 | 09 | 10 | 11 | 14 | 15 | 16 | 17 | 18 | 21 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Winmark Technical Analysis
Jul 8 | Jul 9 | Jul 10 | Jul 11 | Jul 14 | Jul 15 | Jul 16 | Jul 17 | Jul 18 | Jul 21 | |
---|---|---|---|---|---|---|---|---|---|---|
Jul | ||||||||||
08 | 09 | 10 | 11 | 14 | 15 | 16 | 17 | 18 | 21 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |